Results 121 to 130 of about 13,526 (188)

Progressive Fibrosing Lung Disease Treated With Nintedanib in a Patient With Long-Standing Autoimmune Pulmonary Alveolar Proteinosis: A Case Report. [PDF]

Case Rep Pulmonol
Zaizen Y, Nikaido Y, Jimi T, Kawano T, Ichiki K, Tsuda T, Hoshino T.   +6 more
europepmc   +1 more source

Development and <i>In Vitro</i>/<i>In Vivo</i> Characterization of Surface-Modified Nintedanib-Loaded Nanoparticles for Enhanced Bioavailability in Chronic Kidney Disease. [PDF]

ACS Omega
Prajapati VM, Choudhury AD, Kumar A, Rathore M, Sharma G, Singh T, Farswan TS, Singh A, Rayiti R, Ghosh S, Kumar R, Guha R, Kshatri AS, Bhatta RS, Pant AB, Rath SK.   +15 more
europepmc   +1 more source

Pamufetinib (TAS-115) for chronic fibrosing interstitial lung diseases with a progressive phenotype: a double-blind, multicenter, phase 2b clinical trial. [PDF]

Am J Respir Crit Care Med
Okuda R, Nishioka Y, Kondoh Y, Tsubouchi K, Okamoto M, Nishiyama O, Sato S, Oishi K, Ishikawa N, Chiba H, Miyazaki Y, Homma S, Ogura T, Inoue Y, Azuma A.   +14 more
europepmc   +1 more source

Prevent or Treat? Evaluating a Delayed Treatment With Nintedanib After Murine Orthotopic Tracheal Transplantation. [PDF]

Transplant Direct
Mauer J, Graebner C, Kuckhahn A, Ramsperger-Gleixner M, Weyand M, Heim C.   +5 more
europepmc   +1 more source

Nerandomilast in progressive pulmonary fibrosis: data from the whole follow-up period of the FIBRONEER-ILD trial. [PDF]

Eur Respir J
Wijsenbeek MS, Assassi S, Azuma A, Cottin V, Hoffmann-Vold AM, Maher TM, Martinez FJ, Oldham JM, Richeldi L, Valenzuela C, Gu H, Ritter I, Stowasser S, Kreuter M, FIBRONEER-ILD Trial Investigators.   +14 more
europepmc   +1 more source

Evaluation of Serum Prolidase as a Biomarker and the Effects of Nintedanib in an Experimental Rat Model of Silicosis. [PDF]

J Clin Med
Aydın EN, Ergün D, Ergün R, Öztürk B, Ateş MB, Koçak ST, Güvendik MMS.   +6 more
europepmc   +1 more source

Nintedanib Enhances the Antibacterial Activity of Bedaquiline Against Non-Tuberculous Mycobacteria: In vitro and in Mice Models. [PDF]

Infect Drug Resist
Dong S, Li X, Zhang W, Chen X, Lu Y.
europepmc   +1 more source

Association between serum anti-granulocyte-macrophage colony-stimulating factor autoantibodies and nintedanib-induced diarrhea in interstitial lung disease: a retrospective study. [PDF]

J Thorac Dis
Arai T, Hiramatsu M, Takeuchi N, Takimoto T, Kagawa T, Shintani R, Moda M, Hirose M, Nakayama T, Yasui Y.   +9 more
europepmc   +1 more source

Real-World Experience with Nintedanib in a Progressive Pulmonary Fibrosis Cohort. [PDF]

Medicina (Kaunas)
Vicens-Zygmunt V, Bordas-Martínez J, Muñoz-Bolaño M, Carmezim J, Llanos-González AB, Domingo-Carnice A, Rodríguez-Cumplido D, Bermudo-Peloche G, Tebé-Cordomí C, Peñafiel J, Llop-Rius R, Molina-Molina M.   +11 more
europepmc   +1 more source

Fibrotic remodeling in the NOD/ShiLtJ mouse model of Sjögren's disease: insights from single-cell transcriptomics and AI-driven ECM quantification. [PDF]

Front Immunol
Morrissey JM, Nelson DA, Chen L, Petitjean M, Tavarez JR, Altrieth-Flagg AL, Moskwa NL, Williams-Atkinson R, Fowler B, Pena R, Weston K, Kumar N, Aist N, Larsen M.   +13 more
europepmc   +1 more source